Personlized Products Cb-03-1 - GnRH Antagonist Used for Peptides Synthesis – Gentolex
Personlized Products Cb-03-1 - GnRH Antagonist Used for Peptides Synthesis – Gentolex Detail:
Product Detail
|
NO |
Products |
CAS No. |
Application |
Key Quality Indicator |
||||
|
Purity |
Isomer |
Specific impurity |
*Max1 |
Moisture |
||||
|
1 |
Fmoc-3-(2-naphthyl)-D-Ala-OH |
138774-94-4 |
Most products |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
2 |
Ac-3-(2-naphthyl)-D-Ala-OH |
37440-01-0 |
Most products |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
3 |
Fmoc-3-(3-pyridinyl)-D-Ala-OH |
142994-45-4 |
Most products |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
4 |
Fmoc-4-chloro-D-Phe-OH |
142994-19-2 |
Most products |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
5 |
Fmoc-D-Cit-OH |
200344-33-8 |
Cetrorelix |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
6 |
Fmoc-D-Ala-OH.H2O |
79990-15-1 |
Most products |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤6.5% |
|
7 |
Fmoc-D-Aph(tBuCbm)-OH |
1433975-21-3 |
Degarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
8 |
Fmoc-D-Aph(Cbm)-OH |
324017-22-3 |
Degarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
9 |
Fmoc-L-Aph(L-Hor)-OH |
1253282-31-3 |
Degarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
10 |
Fmoc-L-Lys(iPr,Boc)-OH |
201003-48-7 |
Degarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
11 |
Fmoc-N-Me-Tyr(tBu)-OH |
133373-24-7 |
Abarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
12 |
Fmoc-D-Asn(Trt)-OH |
180570-71-2 |
Abarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
13 |
Fmoc-HomoArg(Et)2-OH.HCl |
1864003-26-8 |
Ganirelix |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤2.0% |
|
14 |
Fmoc-D-HomoArg(Et)2-OH.HCl |
2098497-24-4 |
Ganirelix |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤2.0% |
|
15 |
Fmoc-Lys(nicotinoyl)-OH |
252049-11-9 |
Antide |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
16 |
Fmoc-D-Lys(nicotinoyl)-OH |
252049-12-0 |
Antide |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
* Max1 = Max Unknown Impurity
Other Indicator:
- Acetic Acid: ≤0.02% (All Products)
- Ethyl Acetate: ≤0.5% (All Products)
- Alcohol: ≤0.5% (All Products)
TOC and Conductivity
TOC and conductivity of main supply and return points are monitored periodically. TOC is monitored by QC on every week. Conductivity is monitored online and recorded by purified water station operator once every four hours. The conductivity is monitored at the primary RO, secondary RO, EDI and total return point of distribution system. The specification of purified water is in place and conforms to pre-defined specification which no more than 1.3 µs/cm at 25°C (USP). For main supply and return points, full test. is performed every week, for other using point in the circulating loop, full test is performed once every month. The full test includes characters, pH, nitrate, nitrite, ammonia, conductivity, TOC, non-volatile substances, heavy metals, microbial limits and bacterial endotoxin.
Product detail pictures:
Related Product Guide:
So as to provide you with ease and enlarge our business, we even have inspectors in QC Crew and guarantee you our best company and solution for Personlized Products Cb-03-1 - GnRH Antagonist Used for Peptides Synthesis – Gentolex , The product will supply to all over the world, such as: Rome, Latvia, Bahamas, We critically promise that we deliver all the customers with the best quality solutions, the most competitive prices and the most prompt delivery. We hope to win a resplendent future for customers and ourselves.
By Erica from San Diego - 2018.07.27 12:26
The customer service staff's answer is very meticulous, the most important is that the product quality is very good, and packaged carefully, shipped quickly!
By Marjorie from Sao Paulo - 2017.10.27 12:12
Related PRODUCTS
-
2022 China New Design 2,5-Diaminotoluene Sulfat...
-
Wholesale Body Growth - 2,6-Dihydroxy-3-cyano-...
-
Big discounting Common Amino Acids - Atosiban ...
-
High reputation Acetyl Tributyl Citrate 77-90-7...
-
Personlized Products Butylcyclohexyl Acetate -...
-
Hot New Products Antipsychotic - Paclitaxel 33...